ScholarIQanswers from OpenAlex

Belimumab: a step forward in the treatment of systemic lupus erythematosus

PaperCitations, authors & open-access status

Belimumab: a step forward in the treatment of systemic lupus erythematosus is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Belimumab: a step forward in the treatment of systemic lupus erythematosus have?

ScholarIQcitation count

Belimumab: a step forward in the treatment of systemic lupus erythematosus has 16 citations in the OpenAlex counts ScholarIQ stores.

When was Belimumab: a step forward in the treatment of systemic lupus erythematosus published?

ScholarIQyear

Belimumab: a step forward in the treatment of systemic lupus erythematosus has 2021 year in the ScholarIQ index.

What is the open-access status of Belimumab: a step forward in the treatment of systemic lupus erythematosus?

ScholarIQoa status

Belimumab: a step forward in the treatment of systemic lupus erythematosus has closed oa status in the ScholarIQ index.

What is the DOI of Belimumab: a step forward in the treatment of systemic lupus erythematosus?

ScholarIQdoi

The DOI for Belimumab: a step forward in the treatment of systemic lupus erythematosus is on the source record.

What is the PMID of Belimumab: a step forward in the treatment of systemic lupus erythematosus?

ScholarIQpmid

The PMID for Belimumab: a step forward in the treatment of systemic lupus erythematosus is on the source record.

What is the OpenAlex record for Belimumab: a step forward in the treatment of systemic lupus erythematosus?

ScholarIQopenalex

The OpenAlex for Belimumab: a step forward in the treatment of systemic lupus erythematosus is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial